Biden halts program that brings down cost of insulin, EpiPens
One focus during the Trump administration was lowering prescription drug costs, especially for low-income individuals. When he struck a deal with Big Pharma to lower the cost of insulin and epinephrine (EpiPens) for low-income patients, the White House rightly celebrated the accomplishment. Now the Biden administration has halted that initiative. Why does Joe Biden want to raise the price of such lifesaving drugs to those in greatest economic need?